Selected Publications
Richard W. Tsien, Evan C. Rosenberg : Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio. Molecular Pharmacology 107(3): 100017, February 2025.Rosenberg EC, Goldberg EM.: Don't Give Me Lip: A Role for Lipid-Accumulated Reactive Astrocytes in Temporal Lobe Epilepsy. Epilepsy Curr 23: 321-323, Jun 2023.
Rosenberg EC, Chamberland S, Bazelot M, Nebet ER, Wang X, McKenzie S, Jain S, Greenhill S, Wilson M, Marley N, Salah A, Bailey S, Patra PH, Rose R, Chenouard N, Sun SED, Jones D, Buzsáki G, Devinsky O, Woodhall G, Scharfman HE, Whalley BJ, Tsien RW.: Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity. Neuron 111: 1282-1300, Apr 2023.
Rosenberg EC, Lippman-Bell JJ, Handy M, Soldan SS, Rakhade S, Hilario-Gomez C, Folweiler K, Jacobs L, Jensen FE.: Regulation of seizure-induced MeCP2 Ser421 phosphorylation in the developing brain. Neurobiol Dis 2018.
Rosenberg EC, Louik J, Conway E, Devinsky O, Friedman D.: Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol. Epilepsia 2017.
Rosenberg EC, Patra PH, Whalley BJ.: Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection. Epilepsy Behav 2017.
French JA, Koepp M, Naegelin Y, Vigevano F, Auvin S, Rho JM, Rosenberg E, Devinsky O, Olofsson PS, Dichter MA.: Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia 2017.
Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O.: Cannabinoids and Epilepsy. Neurotherapeutics 2015.
Obeid M, Rosenberg EC, Klein PM, Jensen FE.: Lestaurtinib (CEP-701) attenuates "second hit" kainic acid-induced seizures following early life hypoxic seizures. Epilepsy Res 2014.